PURE Bioscience Reports Fiscal Year Revenue of $2.31 Million and GAAP EPS of -$0.02
PURE Bioscience has released its fiscal year financial results, reporting a GAAP earnings per share (EPS) of -$0.02. The company achieved total revenue of $2.31 million, representing a 5.5% increase compared to the previous year. While the company continues to operate at a slight net loss on a GAAP basis, the year-over-year revenue growth indicates steady top-line expansion. Investors will be monitoring whether this revenue momentum can eventually lead to improved profitability in upcoming quarters.
Tickers: $PURE
Topics: earnings GAAP EPS revenue growth
Read the full article at Seeking Alpha
Part of the story Knorex Ltd. Reports First Half GAAP EPS of -$0.18 and Revenue of $2.68M (3 articles)